Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
British Journal of Dermatology2020Vol. 184(4), pp. 722–730
Citations Over TimeTop 10% of 2020 papers
Pietro Quaglino, H. Miles Prince, Richard Cowan, Maarten H. Vermeer, Evangelia Papadavid, M. Bagot, O. Servitjie, Emilio Berti, Emmanuella Guenova, Rudolf Stadler, Christiane Querfeld, A.M. Busschots, Emmilia Hodak, Aikaterini Patsatsi, José Antônio Sanches, Milena Maule, Jungmin Yoo, Melogmo Dongmo Yannick Kevin, Paolo Fava, Simone Ribero, Lamberto Zocchi, Marco Rubatto, Maria Teresa Fierro, Ulrike Wehkamp, M. Marshalko, Christina Mitteldorf, Oleg E. Akilov, Pablo L. Ortiz‐Romero, Teresa Estrach, Liisa Väkevä, Paula Enz, Marion Wobser, Mike Bayne, Constanze Jonak, M. Rubeta, Angus Forbes, Andrew Bates, Maxime Battistella, Rasoul Amel-Kashipaz, B. Vydianath, Andrea Combalía, Elisavet Georgiou, Esther Hauben, Eric Hong, Marion Jost, Robert Knobler, Iris Amitay‐Laish, Denis Miyashiro, Jade Cury‐Martins, X. Martínez, Cristina Muniesa, Hadas Prag-Naveh, Alexander Stratigos, Vasiliki Nikolaou, Koen D. Quint, C. Ram‐Wolff, Kerri E. Rieger, René Stranzenbach, Ágota Szepesi, Silvia Alberti Violetti, Felicity Evison, Lorenzo Cerroni, Werner Kempf, Sean Whittaker, Rein Willemze, Y Kim, Julia Scarisbrick
Abstract
Disease characteristics such as presence of plaques and FMF influence physician treatment choices, and SDT was superior to systemic therapy even in patients with such disease characteristics. Consequently, future treatment guidelines for early-stage MF need to address these issues.
Related Papers
- → ADVANCES IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMA(1998)16 cited
- → Cutaneous T-cell lymphoma (mycosis fungoides)(1996)9 cited
- → Efficacy of chlormethine gel in patients with stage I–IIA mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): re-analysis of a randomized phase 2 study(2019)
- → Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study(2019)
- → 43705 Non-invasive molecular analysis for CTCL detection and differentiation from other skin conditions(2023)